Immunological profiling as a means to invigorate personalized cancer therapy

por Hegmans, Joost PJJ, Aerts, Joachim GJV
Publicado 2013

Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma

por Mahaweni, Niken M., Kaijen-Lambers, Margaretha E.H., Dekkers, Jacqueline, Aerts, Joachim G.J.V., Hegmans, Joost P.J.J.
Publicado 2013

COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function

por Veltman, Joris D, Lambers, Margaretha EH, van Nimwegen, Menno, Hendriks, Rudi W, Hoogsteden, Henk C, Aerts, Joachim GJV, Hegmans, Joost PJJ
Publicado 2010

Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based i...

por Noordam, Lisanne, Kaijen, Margaretha E.H., Bezemer, Koen, Cornelissen, Robin, Maat, Lex A.P.W.M., Hoogsteden, Henk C., Aerts, Joachim G.J.V., Hendriks, Rudi W., Hegmans, Joost P.J.J, Vroman, Heleen
Publicado 2018